Stay updated on Durvalumab Consolidation in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Durvalumab Consolidation in NSCLC Clinical Trial page.

Latest updates to the Durvalumab Consolidation in NSCLC Clinical Trial page
- Check6 days agoChange DetectedA new revision entry, Revision: v3.3.2, appears in the study record history, replacing the previous Revision: v3.3.1; layout and data remain otherwise unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check13 days agoChange DetectedFooter revision updated from v3.2.0 to v3.3.1, indicating a minor site version update. It does not alter core content or user-facing functionality, and to avoid alerting on small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check20 days agoChange DetectedAdded a new 'Study Status' entry to the Record History (version 2025-11-04). Removed the government funding notice banner (2025-07-25).SummaryDifference0.6%

- Check34 days agoChange DetectedThe new screenshot adds more record history entries with newer submission dates, while the main study details and page layout remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check63 days agoChange DetectedUpgrade to v3.2.0 with a government operating-status notice and links to status pages; removes the previous v3.1.0 reference.SummaryDifference9%

- Check70 days agoChange DetectedVersion bump from v3.0.2 to v3.1.0. This signals a software update; no other content changes are indicated.SummaryDifference0.2%

Stay in the know with updates to Durvalumab Consolidation in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Durvalumab Consolidation in NSCLC Clinical Trial page.